Navigation Links
Clinical Force Announces that Stiris Research has Selected the Clinical Force CTMS to Manage Clinical Trials
Date:10/15/2009

Clinical Force announces that Stiris Research has selected the Clinical Force CTMS to manage clinical trials. Stiris Research successfully implemented the Clinical Force CTMS in less than 4 weeks. With Clinical Force, Stiris Research anticipates significant study cost efficiencies that it can pass on to its pharmaceutical and biotech clients.

Raleigh, NC, October 16, 2009 -- Clinical Force announces that Stiris Research has selected the Clinical Force CTMS to manage clinical trials.

Stiris Research boasts best in class competencies in Project Management and Monitoring, providing partners and sponsors with dedicated expert teams and flexible SOPs . The next step in their growth model is to automate the clinical trial process by implementing a CTMS. Stiris Research successfully implemented the Clinical Force CTMS in less than 4 weeks. With Clinical Force, Stiris Research anticipates significant study cost efficiencies that it can pass on to its pharmaceutical and biotech clients.

Stiris Research believes the CTMS will further enhance Sponsors' clinical trial experience by providing:

 
  • Real Time access to study information - enabling instant quality checks
  • Customized study reporting - improving reporting quality
  • Investigator payment tracking - reducing administrative time
  • Regulatory document tracking and filing - providing 24/7 access to the trial master file
  • Automatic monitoring report and follow-up letter generation - saving time and cost

Stiris' President Shantal Feltham states it was Clinical Force's innovative implementation approach that led to the CTMS choice. "Stiris is an organization based on a team approach, commitment to service, and innovative problem solving for our clients. Clinical Force brought the same attributes to the CTMS implementation and proved to be the best fit for us and our clients. As Stiris grows, we look forward to offering our clients this expanded service while maintaining cost efficiencies."

Keep up to date on the Stiris Research CTMS project through this webpage. Stiris CTMS Project Status

About Clinical Force

Clinical Force delivers a best in class Clinical Trial Management System (CTMS) to Clinical Research Organizations (CROs) and Sponsors in North and South America, Europe and Africa. Clinical Force customers are successfully using the CTMS to improve their clinical trial execution, saving time and money. As the industry's first SaaS CTMS provider, Clinical Force has the most advanced SaaS solution and the most experience implementing and supporting the SaaS model. The SaaS model benefits Clinical Force customers with rapid and simple installation and a remarkably affordable total cost of ownership. Clinical Force is a rapidly growing, privately held company with strong life science pedigree. To stay close to our customers, Clinical Force has offices in the US and Europe. www.clinicalforce.com

About Stiris Research

Stiris Research is an elite CRO specializing in providing unparalleled Project Management and Monitoring expertise for Phase I-IV clinical trials. Stiris provides functional service or full service clinical trial support for pharmaceutical, biotech, and device companies. We work with our clients to provide customized solutions based on individual needs and resource requirements. Stiris is a certified Woman Owned Business Enterprise through WEConnect Canada, and has been recognized as one of Canada's top Women Entrepreneurial companies. Stiris has also been recognized as an Emerging Growth Company by Profit Magazine . www.stirisresearch.com

###

Read the full story at http://www.prweb.com/releases/CTMS/CROStirisClinicalForce/prweb3047214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):